You are here
Advisory Committee on Vaccines (ACV)
Role of the ACV
The ACV provides independent medical and scientific advice to the Minister for Health and the Therapeutic Goods Administration (TGA) on issues relating to the safety, quality and efficacy of vaccines supplied in Australia including issues relating to pre-market assessment, post-market monitoring and safe use in national immunisation programs.
The Committee is established under Regulation 39F of the Therapeutic Goods Regulations 1990 and the members are appointed by the Minister for Health.
The ACV was established in January 2017, following consolidation of previous functions of the Advisory Committee on the Safety of Vaccines (ACSOV) and the pre-market functions for vaccines of the Advisory Committee on Prescription Medicines (ACPM).
Membership comprises professionals with expertise in specific scientific, medical or clinical fields, or consumer health issues.
Professor Allen Cheng is an infectious diseases physician. His current appointments are as Director, Infection Prevention and Healthcare Epidemiology at Alfred Health, Professor in the Department of Epidemiology and Preventative Medicine at Monash University, and as an Honorary Senior Research Fellow at the Menzies School of Health Research. Professor Cheng has diverse clinical experience in metropolitan and regional hospitals in Australia and internationally, and research interests in clinical infectious diseases, tropical medicine and influenza epidemiology. His PhD thesis was on the bacterial disease melioidosis. Professor Cheng is the Vice-President of the Australasian Society for Infectious Diseases. He has published over 200 peer-reviewed scientific publications. From 2009 to 2016 Professor Cheng was a member of the Advisory Committee on Prescription Medicines, and he is currently a co-chair of the Australian Technical Advisory Group on Immunisation. Professor Cheng provides expertise in the field of infectious diseases in adults and children.
Ms Karen Booth is a registered nurse and accredited immuniser and currently works as a primary health care nurse consultant. She is President of the Australian Primary Health Care Nurses Association, and is a member of the National Immunisation Committee. Other committee and advisory roles have included participation in the Primary Health Care Advisory Group, a taskforce on pandemics, the development of nationally consistent immuniser accreditation programs, and on the Advisory Committee on the Safety of Vaccines throughout its period of operation. Ms Booth provides expertise in vaccine program implementation, the provision of immunisation treatment by an individual, and nursing.
Professor Jim Buttery is a paediatric infectious diseases physician and clinical researcher. He has been the Director of SAEFVIC, the Victorian immunisation safety service, since its formation in 2007. He is the Professor of Paediatric Epidemiology, Monash University; Head, Infection and Immunity, Monash Children's Hospital; and Head, Monash Immunisation, Monash Health. He is a member of the Scientific Board of the Brighton Collaboration and the President of the World Society of Paediatric Infectious Disease, and previously served on the Advisory Committee on the Safety of Vaccines. Professor Buttery provides expertise in infectious diseases in children, epidemiology, vaccine program implementation, and paediatrics.
Dr Jeanine Bygott is a medical practitioner with a specialty in microbiology and experience in travel medicine clinics in Australia and Ireland. Currently a consultant medical microbiologist at Sullivan Nicolaides Pathology, a private pathology laboratory in Queensland, she provides advice to general practitioners on the administration of vaccines. She has completed a Master of Public Health and Tropical Medicine and a Diploma Course in Vaccinology at the Pasteur Institute in Paris. She is also a Fellow of the Royal Australasian College of Pathologists in medical microbiology and virology. Dr Bygott provides expertise in bacteriology, virology, and the provision of immunisation treatment by an individual.
Associate Professor Rosemary Ffrench is a scientist, the Principal Fellow and Head of Viral Immunology Laboratory at the Burnet Institute, the Chief Scientific officer of 360biolabs (a NATA accredited contract research organization that performs assays for the support of early phase clinical trials of new vaccines for both national and international companies) and a consultant to the WHO on maintaining laboratory capacity in emergency settings. Her academic appointment at Monash University includes lecturing on vaccines, infectious diseases and immunology. She has published extensively on human immunity and vaccine development and holds a patent for the MicroCube vaccine platform. Associate Professor Ffrench provides expertise in immunology and vaccine development.
Professor Paul Johnson is an infectious diseases physician in clinical practice and is the Deputy Director of the Infectious Diseases Department at Austin Health. He trained at the Austin Hospital Clinical School and Fairfield Infectious Diseases Hospital before moving to the Department of Microbiology at the Royal Children's Hospital where he commenced a long standing research program on the diagnosis, transmission and environmental reservoir of Mycobacterium ulcerans infections. Professor Johnson continues his clinical role at Austin Health and is conjointly Director, World Health Organisation Collaborating Centre for Mycobacterium ulcerans. Professor Johnson provides expertise in the field of infectious diseases in adults and children.
Professor Kristine Macartney is the Director of the National Centre for Immunisation Research & Surveillance, a paediatric infectious diseases specialist at The Children's Hospital at Westmead, and Professor in the Discipline of Paediatrics and Child Health, University of Sydney. Her doctoral thesis was on rotavirus infection and mucosal immunity. She was the senior technical editor of the Australian Immunisation Handbook (10th edition) and has research interests in viral vaccine preventable diseases, vaccine safety and policy-making. Professor Macartney served on the Advisory Committee on the Safety of Vaccines throughout its period of operation. Professor Macartney provides expertise in the fields of infectious diseases in children, virology, epidemiology and paediatrics.
Professor Lisa Nissen is the Head of the School of Clinical Sciences at the Queensland University of Technology. A registered pharmacist, Professor Nissen was the chair of the Queensland Pharmacists Immunisation Pilot and the research leader for the evaluation of the pilot implementation, tasked with ensuring that the training development was fit for purpose and that the data collected included safety outcomes. She worked with the Australian Pharmacy Council to develop accreditation standards for the vaccination training programs for pharmacists. Her research interests include the quality use of medicines and the factors that influence prescribing. Professor Nissen provides expertise in vaccine program implementation.
Associate Professor Adrienne Torda is a physician specialising in infectious diseases. She is a senior staff specialist in the Department of Infectious Diseases at the Prince of Wales Hospital, Sydney and an Associate Professor in the Faculty of Medicine, UNSW Sydney. She has a PhD, a Graduate Diploma of Bioethics, is an Associate Fellow of the Australia and New Zealand Association of Health Professional Educators and is a Senior Fellow of the Higher Education Academy. Her research interests include translational research topics such as vaccine coverage in vulnerable populations and diabetic foot infections. She is involved in a number of medical education research projects, examining the impact of educational innovations in medicine. From 2004 to 2007 she was a member of the National Influenza Pandemic Committee. Associate Professor Torda provides expertise in infectious diseases in adults and children.
Ms Diane Walsh is the Deputy Chair of the Board of the Northern Territory Primary Health Network (PHN) and is currently on the Advisory Group of the PHN Immunisation Support Program. She previously served as the chair of the Top End Division of General Practice Board of Management for over 10 years, and has been a member of the Northern Territory Medical Board, the management committee of Health Consumers of Rural and Remote Australia, and the National Medicines Policy Committee. Ms Walsh provided the consumer perspective on the statutory Therapeutic Goods Committee, including on medicine labelling. She has worked as a school teacher and operated a small business. Ms Walsh provides expertise in health issues from the consumer perspective.
2020 ACV proposed meeting dates
|Meeting no.||Meeting dates|
|15||3 June 2020|
|16||5 August 2020|
|17||30 September 2020|
|18||2 December 2020|
Contact details for the ACV
|Phone||+61 2 6232 8665|
|Mobile||+61 468 609 842|
|Fax||+61 2 6203 1250|
|Postal Address||Advisory Committee on Vaccines
Therapeutic Goods Administration
PO Box 100
WODEN ACT 2606
Attn: Scheduling & Committee Support Section, MDP 122